Stereotaxis Inc (STXS) Stock Price, Quote & News

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed t...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 314 678 6100

Website: www.stereotaxis.com

Address:

710 North Tucker Boulevard, Suite 110, Saint Louis, United States

alexpitti Aug. 19 at 4:34 PM

$STXS arbiter did sell. i was wrong

0 · Reply

alexpitti Aug. 19 at 2:14 PM

$STXS arbiter didn't sell their shares if that bothers you. personally, i don't care. but please check before you claim things

0 · Reply

jacksonjohn750 Aug. 19 at 1:18 PM

$STXS https://www.facebook.com/BluhmCardiovascularInstitute/posts/pfbid021fArA1xYpTdBVFhttEDbp3nv9m3fJG79ssrpcz5ifdrr2PKtz4Tpi3rfMJ4RsKjFl?rdid=PgoBVYHkzTB9sCEP#

0 · Reply

alexpitti Aug. 18 at 9:51 PM

$STXS inflection point https://cardiovascularbusiness.com/topics/cardiac-imaging/ep-lab/robotics-electrophysiology-are-we-near-inflection-point

0 · Reply

jacksonjohn750 Aug. 18 at 9:15 PM

$STXS When is the next dilution scheduled for?

0 · Reply

alexpitti Aug. 18 at 8:44 PM

start watching 12 minute mark $STXS https://www.youtube.com/watch?v=mKJgXLf3Mfs

0 · Reply

alexpitti Aug. 18 at 7:28 PM

$STXS will be the only player in the ASC for ablations

0 · Reply

zbenz Aug. 17 at 11:22 PM

$STXS Hi all , It looks like that Arbiter Partners dumped all their share in Q2 according to filings that i see ,,, not sure if that was tarsactional on registration of shares , warrants / converts or a fundamental sentiment change as they a key original cohort with DAFNA w cross holdings, BOD etc ,,, can anyone confirm what i see with clarity and confirmation

2 · Reply

DecoderRing Aug. 17 at 8:52 PM

$STXS I'm just relieved that the "Robots, magnets, and heart health, oh my!" demo with Saint Louis Science center went off without a hitch and was a great success. These are the things that are important for a company trying to accelerate growth and awareness. Getting these kids involved at an early stage with robotics fits in nicely with the Stereotaxis long term strategy (5-10yrs) of integrating Robocatch. https://www.facebook.com/STLScienceCenter/posts/robots-magnets-and-heart-health-oh-my-join-us-today-11am-3pm-for-stereotaxis-pop/1375456351456334/

0 · Reply

alexpitti Aug. 14 at 9:13 PM

i bought $ABVX sold $MIST i lost money on $ABEO and $STXS i made money?????? on $DCTH

2 · Reply

Stereotaxis Slides: Investor presentation

2026-08-17T09:31:44.000Z - 2 days ago

Stereotaxis price target lowered to $3 from $4 at Lake Street

2026-08-17T09:29:44.000Z - 2 days ago

Stereotaxis price target lowered to $3 from $5 at TD Cowen

Aug 11, 2026, 4:30 PM EDT - 7 days ago

Stereotaxis Earnings Call Transcript: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 7 days ago

Stereotaxis Earnings release: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 7 days ago

Stereotaxis Quarterly report: Q2 2026

2026-08-11T20:05:25.000Z - 7 days ago

Stereotaxis reports Q2 EPS (5c), consensus (5c)

Aug 11, 2026, 4:01 PM EDT - 7 days ago

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

Jul 21, 2026, 9:00 AM EDT - 4 weeks ago

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026

Jul 20, 2026, 8:31 AM EDT - 4 weeks ago

University of Szeged Pioneers First Robotic Cardiology Program in Hungary

2026-07-15T21:30:19.000Z - 4 weeks ago

Stereotaxis files to sell 108.87M shares of common stock for holders

2026-07-15T21:25:18.000Z - 4 weeks ago

Stereotaxis files to sell 19.45M shares of common stock for holders

Jul 15, 2026, 8:00 AM EDT - 5 weeks ago

Stereotaxis Registration statement: Registration filing

Jul 15, 2026, 8:00 AM EDT - 5 weeks ago

Stereotaxis Registration statement: Registration filing

Jul 9, 2026, 8:08 AM EDT - 5 weeks ago

Stereotaxis Completes Acquisition of Robocath

2026-07-01T20:10:17.000Z - 6 weeks ago

Stereotaxis management to meet with BTIG

Jun 23, 2026, 7:00 AM EDT - 2 months ago

Stereotaxis Slides: Investor presentation

2026-05-13T11:19:51.000Z - 3 months ago

Stereotaxis price target lowered to $3.50 from $4 at Piper Sandler

JNJ

May 12, 2026, 4:30 PM EDT - 3 months ago

Stereotaxis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Stereotaxis Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Stereotaxis Quarterly report: Q1 2026

May 12, 2026, 4:06 PM EDT - 3 months ago

Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates

Apr 22, 2026, 7:58 AM EDT - 4 months ago

Stereotaxis Announces First MAGiC Procedures in the United States

Apr 21, 2026, 9:01 AM EDT - 4 months ago

Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

Apr 15, 2026, 9:00 AM EDT - 4 months ago

Stereotaxis Transcript: M&A announcement

Apr 15, 2026, 9:00 AM EDT - 4 months ago

Stereotaxis Press release: M&A announcement

2026-04-15T11:12:19.000Z - 4 months ago

Stereotaxis to acquire Robocath, terms undisclosed

Apr 15, 2026, 7:00 AM EDT - 4 months ago

Stereotaxis Announces Definitive Agreement to Acquire Robocath

2026-04-06T12:40:34.000Z - 4 months ago

Stereotaxis receives FDA clearance for Synchrony system

Apr 6, 2026, 8:06 AM EDT - 4 months ago

Stereotaxis Announces FDA Clearance and Launch of Synchrony System

Apr 3, 2026, 8:00 AM EDT - 4 months ago

Stereotaxis Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 4 months ago

Stereotaxis Proxy statement: Proxy filing

2026-03-13T20:30:19.000Z - 5 months ago

Stereotaxis files $100M mixed securities shelf

2026-03-13T19:35:41.000Z - 5 months ago

Stereotaxis management to meet virtually with BTIG

Mar 13, 2026, 8:00 AM EDT - 5 months ago

Stereotaxis Registration statement: Registration Filing

Mar 9, 2026, 4:30 PM EDT - 5 months ago

Stereotaxis Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

Stereotaxis Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

Stereotaxis Earnings release: Q4 2025

2026-03-09T20:05:19.000Z - 5 months ago

Stereotaxis reports Q4 EPS (6c), consensus (6c)

2026-03-09T20:05:10.000Z - 5 months ago

Stereotaxis sees FY26 revenue up double digits

Mar 9, 2026, 4:01 PM EDT - 5 months ago

Stereotaxis Reports 2025 Full Year Financial Results

Feb 12, 2026, 9:00 AM EST - 6 months ago

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026

2026-02-09T13:37:08.000Z - 6 months ago

Stereotaxis announces launch of electrophysiology program at Klinikum Furth

Feb 9, 2026, 8:06 AM EST - 6 months ago

Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program

2026-01-06T13:39:16.000Z - 8 months ago

Stereotaxis reports FDA approval for MAGiC Ablation Catheter

Jan 6, 2026, 8:01 AM EST - 8 months ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

2025-12-16T09:40:34.000Z - 8 months ago

Stereotaxis initiated with an Outperform at Citizens

Nov 24, 2025, 8:58 AM EST - 9 months ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 11, 2025, 4:30 PM EST - 10 months ago

Stereotaxis Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:30 PM EST - 10 months ago

Stereotaxis Quarterly report: Q3 2025

Nov 11, 2025, 4:30 PM EST - 10 months ago

Stereotaxis Earnings release: Q3 2025

2025-11-11T21:05:25.000Z - 10 months ago

Stereotaxis reports Q3 EPS (7c), consensus (6c)

Nov 11, 2025, 4:01 PM EST - 10 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results

2025-11-10T22:01:01.000Z - 10 months ago

Stereotaxis announces FDA clearance for GenesisX

Nov 10, 2025, 4:05 PM EST - 10 months ago

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

2025-11-05T09:25:11.000Z - 10 months ago

Stereotaxis resumed with a Buy at Roth Capital

Oct 21, 2025, 9:00 AM EDT - 10 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 15, 2025, 7:32 AM EDT - 11 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Oct 13, 2025, 7:34 AM EDT - 11 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Sep 22, 2025, 7:56 AM EDT - 11 months ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

Sep 2, 2025, 8:08 AM EDT - 1 year ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Sep 2, 2025, 7:51 AM EDT - 1 year ago

Stereotaxis to Present at Upcoming Investor Conferences

Aug 28, 2025, 7:47 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings release: Q2 2025

Aug 7, 2025, 4:01 PM EDT - 1 year ago

Stereotaxis Reports 2025 Second Quarter Financial Results

Jul 28, 2025, 7:48 AM EDT - 1 year ago

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 23, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 17, 2025, 8:32 AM EDT - 1 year ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 1, 2025, 9:00 AM EDT - 1 year ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings release: Q1 2025

May 12, 2025, 4:01 PM EDT - 1 year ago

Stereotaxis Reports 2025 First Quarter Financial Results

Apr 22, 2025, 7:00 AM EDT - 1 year ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 10, 2025, 8:02 AM EDT - 1 year ago

Stereotaxis to Present at 37th Annual Roth Conference

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Annual report: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings release: Q4 2024

Mar 3, 2025, 7:32 AM EST - 1 year ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:31 AM EST - 1 year ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:30 AM EST - 1 year ago

Stereotaxis Reports 2024 Full Year Financial Results

Feb 25, 2025, 8:03 AM EST - 1 year ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 3, 2025, 4:05 PM EST - 1 year ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order

Jan 27, 2025, 8:00 AM EST - 1 year ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 14, 2025, 7:21 AM EST - 1 year ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Dec 9, 2024, 7:25 AM EST - 1 year ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 2, 2024, 8:45 AM EST - 1 year ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Nov 26, 2024, 8:28 AM EST - 1 year ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 8:21 AM EST - 1 year ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 20, 2024, 8:18 AM EST - 1 year ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Quarterly report: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings release: Q3 2024

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Oct 21, 2024, 8:41 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Sep 6, 2024, 8:00 AM EDT - 2 years ago

Stereotaxis Registration statement: Registration Filing

Sep 3, 2024, 8:53 AM EDT - 2 years ago

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Aug 23, 2024, 8:00 AM EDT - 2 years ago

Stereotaxis Registration statement: Registration Filing

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Quarterly report: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Earnings release: Q2 2024

Aug 12, 2024, 4:05 PM EDT - 2 years ago

Stereotaxis Reports 2024 Second Quarter Financial Results

alexpitti Aug. 19 at 4:34 PM

$STXS arbiter did sell. i was wrong

0 · Reply

alexpitti Aug. 19 at 2:14 PM

$STXS arbiter didn't sell their shares if that bothers you. personally, i don't care. but please check before you claim things

0 · Reply

jacksonjohn750 Aug. 19 at 1:18 PM

$STXS https://www.facebook.com/BluhmCardiovascularInstitute/posts/pfbid021fArA1xYpTdBVFhttEDbp3nv9m3fJG79ssrpcz5ifdrr2PKtz4Tpi3rfMJ4RsKjFl?rdid=PgoBVYHkzTB9sCEP#

0 · Reply

alexpitti Aug. 18 at 9:51 PM

$STXS inflection point https://cardiovascularbusiness.com/topics/cardiac-imaging/ep-lab/robotics-electrophysiology-are-we-near-inflection-point

0 · Reply

jacksonjohn750 Aug. 18 at 9:15 PM

$STXS When is the next dilution scheduled for?

0 · Reply

alexpitti Aug. 18 at 8:44 PM

start watching 12 minute mark $STXS https://www.youtube.com/watch?v=mKJgXLf3Mfs

0 · Reply

alexpitti Aug. 18 at 7:28 PM

$STXS will be the only player in the ASC for ablations

0 · Reply

zbenz Aug. 17 at 11:22 PM

2 · Reply

DecoderRing Aug. 17 at 8:52 PM

0 · Reply

alexpitti Aug. 14 at 9:13 PM

i bought $ABVX sold $MIST i lost money on $ABEO and $STXS i made money?????? on $DCTH

2 · Reply

jacksonjohn750 Aug. 13 at 4:54 PM

$STXS we need Alex to write up another Seeking Alpha pump!!

1 · Reply

zbenz Aug. 13 at 3:00 PM

$STXS Any thoughts on why they don't mention a word about APT operations and what products they are supplying into the "ecosystem" ...and on the conspracy front , ...any thoughts if Osypka is purposely dragging their feet on Magic because they realize that eventually the production will be "in house"

0 · Reply

laguna2 Aug. 13 at 2:27 PM

$STXS Turning 5-8K recurring revs per procedure (in the US) is a nice thing. The ducks are lined up in the EP space. IMO a raise is required to shore up the balance sheet to fund what is needed to be done in the IC space. The amount depends on the intensity of effort they plan on addressing that market. If fast is better, than ~50M raise would be my guess assuming extra R&D spend of 5M/q over 3 yrs.

1 · Reply

alexpitti Aug. 13 at 4:57 AM

$STXS

0 · Reply

brunoq14 Aug. 13 at 4:27 AM

$STXS Hopjng this technical collapse of the share price will turn out to have been a buying opportunity. My basis is down to 1.67.

1 · Reply

alexpitti Aug. 12 at 6:02 PM

think about it. Stereotaxis is entering new labs with synchrony sales. it won't be that hard to sell them some map it catheters. then sell a genesisx soon after $STXS

1 · Reply

S144 Aug. 12 at 4:18 PM

Its a pitti $STXS failed to deliver again ..

1 · Reply

anachartanalyst Aug. 12 at 4:02 PM

$STXS https://anachart.com/wp-content/uploads/2026/08/1786550509_soc-img.jpg

0 · Reply

jacksonjohn750 Aug. 12 at 1:52 PM

$STXS @alexpitti time to sell this and buy $PCT? LOL

0 · Reply

alexpitti Aug. 12 at 11:55 AM

no volume for $STXS yet. let's see what the day brings

0 · Reply

alexpitti Aug. 12 at 12:03 AM

it has been awhile but $STXS is finally getting their first 2 GenesisX's installed and treating patients in the next 2-3 months. MAGiC is finally being produced. But we need to wait until next year to get big GenesisX orders.

2 · Reply

StocktwitsEarnings Aug. 11 at 9:17 PM

$STXS Q2 '26 Earnings Results & Recap Stereotaxis anticipates recurring revenue to grow to approximately $7 million in the third quarter and $8 million in the fourth quarter, with system revenue expected at $3 million for each period.

0 · Reply

Market Cap	136.13M
Revenue (ttm)	32.38M
Net Income (ttm)	-21.64M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-66.83%
Debt to Equity Ratio	0.00

Volume	523,523
Avg Vol	915,514
Day's Range	N/A - N/A
Shares Out	97.93M
Stochastic %K	30%
Beta	1.37
Analysts	Strong Sell
Price Target	$3.67